SeekingAlpha · Oct 13, 2026
Sana Biotechnology: A Shot At Diabetes
Sana Biotechnology trades at a steep discount despite promising T1D assets UP421 and SC451. Check out why SANA stock is a buy.
SA
NASDAQ · SANA
Sana Biotechnology, Inc.
Healthcare · Biotechnology
$2.33
Up+$0.01 (+0.43%)
Updated Oct 26, 2026, 3:43 PM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.33B
- P/E ratio
- -4.72
- Dividend yield
- 0.00%
- 52-week range
- $2.22 – $4.22
- Volume
- 1.71M
- Avg. volume
- 5.83M
Price performance · SANA
SANA price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 23, 2026
SANA closed at $2.33 after 20 trading sessions, down 20.48% for the selected period.
- Last close
- $2.33
- Period change
- -20.48%
- Period low
- $2.27
- Period high
- $2.93
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | $2.35 | $2.38 | $2.245 | $2.33 | 1.71M |
| Oct 22, 2026 | $2.325 | $2.44 | $2.28 | $2.37 | 2.43M |
| Oct 21, 2026 | $2.38 | $2.39 | $2.315 | $2.35 | 2.4M |
| Oct 20, 2026 | $2.27 | $2.42 | $2.25 | $2.36 | 3.53M |
| Oct 19, 2026 | $2.32 | $2.3588 | $2.22 | $2.30 | 2.63M |
| Oct 16, 2026 | $2.46 | $2.51 | $2.25 | $2.27 | 3.09M |
| Oct 15, 2026 | $2.36 | $2.51 | $2.35 | $2.475 | 2.92M |
| Oct 14, 2026 | $2.37 | $2.4299 | $2.32 | $2.33 | 2.77M |
| Oct 13, 2026 | $2.60 | $2.6347 | $2.37 | $2.41 | 4.91M |
| Oct 12, 2026 | $2.77 | $2.77 | $2.59 | $2.62 | 2.67M |
| Oct 9, 2026 | $2.79 | $2.87 | $2.7701 | $2.79 | 2.92M |
| Oct 8, 2026 | $2.72 | $2.81 | $2.66 | $2.79 | 4.52M |
| Oct 7, 2026 | $2.71 | $2.845 | $2.70 | $2.72 | 4.32M |
| Oct 6, 2026 | $2.94 | $2.975 | $2.74 | $2.75 | 3.76M |
| Oct 5, 2026 | $2.90 | $2.93 | $2.82 | $2.88 | 5.39M |
| Oct 2, 2026 | $2.95 | $3.00 | $2.855 | $2.89 | 3.5M |
| Oct 1, 2026 | $2.89 | $3.05 | $2.85 | $2.89 | 3.77M |
| Sep 30, 2026 | $2.97 | $3.045 | $2.855 | $2.915 | 3.25M |
| Sep 29, 2026 | $2.945 | $3.055 | $2.89 | $2.91 | 3.05M |
| Sep 28, 2026 | $2.92 | $2.98 | $2.86 | $2.93 | 2.27M |
Latest SANA news
The latest Smart Investors Daily articles mentioning SANA.
Stock researchCompany · Overview
Company
Market Activity
Research & News
SANA research
Overview
Company profile and research snapshot.
Company profile
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $8.00
- Implied upside
- —
- Analysts
- 15
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 14, 2026 | B of A Securities | Buy | — |
| Apr 14, 2026 | Wedbush | Outperform | — |
| Mar 4, 2026 | HC Wainwright & Co. | Buy | — |
| Jan 6, 2026 | B of A Securities | Buy | — |
| Nov 7, 2025 | Wedbush | Outperform | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Sep 14, 2026
Sana Biotechnology, Inc. (SANA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Sana Biotechnology, Inc. (SANA) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 4:50 PM EDTCompany ParticipantsSteven Harr -...
SeekingAlpha · Sep 10, 2026
Sana Biotechnology, Inc. (SANA) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript
SeekingAlpha · Sep 10, 2026
Sana Biotechnology, Inc. (SANA) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Sana Biotechnology, Inc. (SANA) Wells Fargo 21st Annual Healthcare Conference September 8, 2026 9:30 AM EDTCompany ParticipantsSteven Harr - President, CEO...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
